Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy.
Publication/Presentation Date
2-1-2022
Abstract
Chimeric antigen receptor (CAR) T-cell therapy represents a new strategy in treating lymphoid malignancies, such as relapsed-refractory diffuse large B-cell lymphoma (DLBCL). Several toxicities including cytokine release syndrome (CRS), neurotoxicity, and cardiovascular toxicity have been linked to CAR T-cell therapy. Transient impairment in left ventricular systolic function is described after CAR-T, however, the mechanism remains poorly understood. This paper reports the clinical presentation and outcome of two patients with relapsed-refractory DLBCL who experienced encephalopathy and CRS following CAR T-cell therapy and developed transient left ventricular dysfunction consistent with stress cardiomyopathy.
Volume
3
Issue
1
First Page
231
Last Page
234
ISSN
2688-6146
Published In/Presented At
Khorasanchi, A., Ansari, A. M., Bottinor, W., Simmons, G., Abbate, A., & Toor, A. A. (2021). Transient left ventricular dysfunction following chimeric antigen receptor T-cell-mediated encephalopathy: A form of stress cardiomyopathy. EJHaem, 3(1), 231–234. https://doi.org/10.1002/jha2.369
Disciplines
Medicine and Health Sciences
PubMedID
35846197
Department(s)
Department of Medicine, Hematology-Medical Oncology Division
Document Type
Article